Samantha Prout Amicus Therapeutics, Inc. (FOLD) insider trading activity

Samantha Prout is Chief Accounting Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 73,926 shares of FOLD, which is worth approximately $714,125. The most recent transaction as insider was on Apr 15, 2024, when has been sold 7,027 shares (Common Stock) at a price of $10.66 per share, resulting in proceeds of $74,907. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.9K

0% 3M change

42.95% 12M change

Total Value Held $714,125

Samantha Prout Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 15 2024	SELL Payment of exercise price or tax liability	$74,907 $10.66 p/Share	7,027 Reduced 8.68%	73,926 Common Stock
Jan 09 2024	SELL Open market or private sale	$18,718 $14.0 p/Share	1,337 Reduced 1.62%	80,953 Common Stock
Jan 08 2024	SELL Open market or private sale	$430,738 $14.0 p/Share	30,767 Reduced 27.21%	82,290 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$17,418 $13.44 p/Share	1,296 Reduced 1.13%	113,057 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$110,161 $13.53 p/Share	8,142 Reduced 6.65%	114,353 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$18,697 $14.24 p/Share	1,313 Reduced 1.06%	122,495 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	25,252 Added 16.94%	123,808 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$331,421 $14.19 p/Share	23,356 Reduced 19.16%	98,556 Common Stock
Dec 26 2023	SELL Open market or private sale	$107,226 $14.0 p/Share	7,659 Reduced 5.91%	121,912 Common Stock
Aug 17 2023	SELL Payment of exercise price or tax liability	$94,906 $12.77 p/Share	7,432 Reduced 5.42%	129,571 Common Stock
Aug 09 2023	SELL Open market or private sale	$517,095 $14.01 p/Share	36,909 Reduced 21.22%	137,003 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$384,960 $10.43 p/Share	36,909 Added 17.51%	173,912 Common Stock
Sep 03 2021	SELL Open market or private sale	$59,149 $12.01 p/Share	4,925 Reduced 5.59%	83,170 Common Stock
Sep 03 2021	BUY Exercise of conversion of derivative security	$48,265 $9.8 p/Share	4,925 Added 5.29%	88,095 Common Stock
Aug 23 2021	SELL Open market or private sale	$55,495 $11.0 p/Share	5,045 Reduced 5.72%	83,170 Common Stock
Apr 15 2021	SELL Payment of exercise price or tax liability	$6,818 $10.33 p/Share	660 Reduced 0.74%	88,215 Common Stock
Apr 15 2021	BUY Grant, award, or other acquisition	-	24,201 Added 21.4%	88,875 Common Stock
Mar 26 2021	SELL Payment of exercise price or tax liability	$4,172 $9.59 p/Share	435 Reduced 0.67%	64,674 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	10,533 Added 28.63%	26,255 Common Stock
Jan 02 2021	SELL Payment of exercise price or tax liability	$32,626 $23.09 p/Share	1,413 Reduced 8.25%	15,722 Common Stock
Nov 04 2020	SELL Open market or private sale	$118,620 $20.0 p/Share	5,931 Reduced 25.71%	17,135 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$73,900 $12.46 p/Share	5,931 Added 20.45%	23,066 Common Stock
Aug 17 2020	BUY Grant, award, or other acquisition	-	30,181 Added 31.67%	65,109 Common Stock
Apr 15 2020	BUY Grant, award, or other acquisition	-	8,673 Added 19.89%	34,928 Common Stock

Samantha Prout

Chief Accounting Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account